검색
Home
National
All
Politics
Social Affairs
Foreign Affairs
Defense
North Korea
Diplomatic Circuit
K-Wellness
Business
All
Industry
Technology
Mobility
Economy
Market
Life&Culture
All
Culture
Travel
Food
Books
People
Arts & Design
Film
Television
Performance
Sports
All
Soccer
Baseball
Golf
More Sports
World
All
World News
World Business
Opinion
All
Editorial
Viewpoints
K-pop
한국어판
More +
Weekender
English Eye
Podcast
Interactive
PR newswire
Global insight
Send E-mail
Medipost obtains US patent related to cartilage defect treatment
Medipost (078160) has obtained a US patent related to cartilage defect treatment, it announced on June 29.
From
Send to
Close
Send
Link copied
15:12
Battle of petitions is latest in Hybe-Ador dispute
15:05
Outgoing speaker calls for immediate start of pension reform
14:54
LG Energy Solution hosts recruitment event in New York
14:18
Yoon shares kimchi stew with reporters
14:01
KRX CEO pledges to turn Korea discount into premium
14:00
[KH Explains] US crackdown on Chinese connected vehicles unsettles S. Korea
13:56
[From the Scene] Porsche’s Leipzig plant shines with people-first orientation
13:55
Hyundai Steel sharpens edge to ride out tough market
13:48
Genesis BBQ opens new US stores in Omaha
11:22
S. Korea, Japan, China to hold 1st summit in 4 1/2 years to discuss cooperation
Medipost obtains US patent related to cartilage defect treatment
June 29, 2016 - 14:28
By 황유미
[DISCLOSURE]
Medipost
(078160) has obtained a US patent related to cartilage defect treatment, it announced on June 29.
황유미
Most Popular
1
Yoon rejects Lee's proposal for pension reform talks
2
US girding for possibility of N. Korea taking most provocative military actions in decade near election: NBC
3
Korea signs off on new med school quotas
4
Ottogi heir joins family business in US
5
6 out of 10 Koreans don’t plan to have babies
6
Income, education level increased for arranged international marriage: report
